Davis, Sharon E.
Zabotka, Luke
Desai, Rishi J.
Wang, Shirley V.
Maro, Judith C.
Coughlin, Kevin
Hernández-Muñoz, José J.
Stojanovic, Danijela
Shah, Nigam H.
Smith, Joshua C.
Funding for this research was provided by:
U.S. Food and Drug Administration (75F40119D10037, 7540119F19002)
Article History
Accepted: 31 May 2023
First Online: 20 June 2023
Declarations
:
: This project was supported by Task Order 7540119F19002 under Master Agreement 75F40119D10037 from the US FDA. The FDA reviewed and approved this manuscript, however they had no role in data collection, management, or analysis. The views expressed represent those of the authors and do not necessarily represent the official views of the FDA.
: Sharon E. Davis, Luke Zabotka, Rishi J. Desai, Shirley V. Wang, Judith C. Maro, Kevin Coughlin, José J. Hernández-Muñoz, Danijela Stojanovic, Nigam H. Shah, and Joshua C. Smith declare no competing interests.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: Not applicable.
: SED and JCS designed the study and drafted the initial manuscript. SED, JCS, LZ, and KC contributed to the abstract screening and data extraction for the included studies. RJD, SVW JCM, JJH, DS, and NHS provided critical review of the included studies and interpretation of the results. All authors contributed to the final version of the manuscript and approved submission.